A complete response to tafasitamab and lenalidomide in a patient with refractory grade 3B follicular lymphoma.

Authors

Monique L. Germain, LSU Health Sciences Center - New OrleansFollow
J. Lampenfeld, Tulane University School of Medicine, New Orleans, LA
H. Safah, Tulane University, New Orleans, LA
N.S. Saba, Tulane University, New Orleans, LA

Document Type

Conference Proceeding

Publication Date

2-7-2023

Publication Title

American Journal of the Medical Sciences

Abstract

2023 Southern Regional Meeting, February 2 - 4, 2023, New Orleans, LA

First Page

S369

Last Page

S369

Volume

365

Issue

Supplement 1

Comments

Concurrent Session: Hematology and Oncology II - Abstract 673

Recommended Citation

Germain, Monique L.; Lampenfeld, J.; Safah, H.; and Saba, N.S., "A complete response to tafasitamab and lenalidomide in a patient with refractory grade 3B follicular lymphoma." (2023). School of Medicine Faculty Publications. 2803.
https://digitalscholar.lsuhsc.edu/som_facpubs/2803
10.1016/S0002-9629(23)00680-8